PHARMACY

Rite Aid marks American Diabetes Month with Wellness+, Wellness store programs

BY Alaric DeArment

CAMP HILL, Pa. — Rite Aid is renewing its diabetes extension for Wellness+ and offering free screenings at all of its Wellness stores to mark American Diabetes Month, the retail pharmacy chain said Monday.

Rite Aid said members of its Wellness+ for Diabetes program, which it launched last year, would be eligible for free wellness consultations with pharmacists trained as diabetes care specialists, including access to a toll-free number where they can be connected during regular business hours with a pharmacist. They can also receive a recurring $10 +UP Reward for every $50 spent on certain diabetes products, as well as a 12-page Diabetes Health guide available at any store. In addition, all of the approximately 600 Wellness stores in the chain would offer free health screenings, including diabetes risk, chronic obstructive pulmonary disease and blood pressure; the events will take place on Nov. 14 and Nov. 17.

"Living with diabetes can feel overwhelming, but Rite Aid is committed to making it easier by being a year-round destination for diabetes support," Rite Aid EVP pharmacy Robert Thompson said. "By enrolling in Wellness+ for Diabetes, our customers instantly get a wide range of resources including the ability to call or chat online with a Rite Aid pharmacist specially trained as a diabetes care specialist."

The company will raise money for the American Diabetes Association by selling paper pinups at stores, offering Rite Aid coupons with the pinups.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

FDA approves J&J anti-clotting drug

BY Alaric DeArment

RARITAN, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating internal blood clots, the company said.

J&J subsidiary Janssen Pharmaceuticals announced the approval of Xarelto (rivaroxaban) for treating deep-vein thrombosis and pulmonary embolism and to reduce the risk of recurrence of the clotting conditions after initial treatment.

The company said Xarelto was the first oral anticoagulant approved to treat DVT and PE without the need for injections or routine blood-monitoring.

"Xarelto provides a single-drug treatment option from the moment of diagnosis through the completion of therapy, and in the initial treatment phase, it can cut a patient’s risk of major bleeding by nearly half," New York University School of Medicine professor Jack Ansell said. "Venous blood clots are associated with a high risk of serious complications, so the approval of Xarelto will immediately impact how we treat these patients and may set a new standard of care."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Rx Response mobilizes to help facilitate pharmaceutical distribution as East Coast rebuilds from Sandy

BY Michael Johnsen

WASHINGTON — Rx Response, an initiative of America’s bio-pharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency, has continued its close coordination with federal, state and local government agencies to address impacts from Hurricane Sandy on the bio-pharmaceutical supply system, the organization announced Friday. 

Rx Response officials remain in daily contact with senior officials at the Department of Homeland Security, FEMA and the Department of Health and Human Services, providing updates on Hurricane Sandy’s impact on the medicine supply chain.

A key focal point in the discussions between Rx Response and government agencies has been addressing challenges in getting fuel to delivery trucks re-supplying hospitals and pharmacies, and helping to secure fuel for pharmacies and other healthcare facilities operating on generator power. Efforts are currently underway to help ensure access to fuel for both delivery fleets and healthcare facilities powered by generators.  Rx Response is also working with local law enforcement to help delivery vehicles gain access to areas impacted by Hurricane Sandy.

“We look forward to continuing our close coordination with Rx Response and government agencies to help ensure that our member companies can continue critical deliveries of medicine to hospitals and pharmacies,” stated Perry Fri, SVP industry relations, membership and education for the Healthcare Distribution Management Association, a member of Rx Response and the trade association representing primary healthcare distributors.

In addition, Rx Response also continues to update its Pharmacy Status Reporting Tool, an online program that allows emergency managers and the public to readily locate open pharmacies in communities that have been impacted by severe weather or other events at www.rxresponse.org. Many government agencies also have included links to the PSRT on their websites and in other communications.

“NACDS and its members appreciate the continued efforts by Rx Response to put patients first during this challenging time," stated Steven Anderson, president and CEO for the National Association of Chain Drug Stores. "In activating the Pharmacy Status Reporting Tool, Rx Response provided an incredibly important mechanism to help patients get the medicines they need from community pharmacies in the affected storm areas."

 

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?